Protocol for the mixed-methods process and context evaluation of theTB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness-implementation study
- PMID:29602847
- PMCID: PMC5887198
- DOI: 10.1136/bmjopen-2017-019878
Protocol for the mixed-methods process and context evaluation of theTB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness-implementation study
Abstract
Introduction: Tuberculosis (TB) remains a significant public health problem in South Asia. Tobacco use increases the risks of TB infection and TB progression. TheTB& Tobacco placebo-controlled randomised trial aims to (1) assess the effectiveness of the tobacco cessation medication cytisine versus placebo when combined with behavioural support and (2) implement tobacco cessation medication and behavioural support as part of general TB care in Bangladesh and Pakistan. This paper summarises the process and context evaluation protocol embedded in the effectiveness-implementation hybrid design.
Methods and analysis: We are conducting a mixed-methods process and context evaluation informed by an intervention logic model that draws on the UK Medical Research Council's Process Evaluation Guidance. Our approach includes quantitative and qualitative data collection on context, recruitment, reach, dose delivered, dose received and fidelity. Quantitative data include patient characteristics, reach of recruitment among eligible patients, routine trial data on dose delivered and dose received, and a COM-B ('capability', 'opportunity', 'motivation' and 'behaviour') questionnaire filled in by participating health workers. Qualitative data include semistructured interviews with TB health workers and patients, and with policy-makers at district and central levels in each country. Interviews will be analysed using the framework approach. The behavioural intervention delivery is audio recorded and assessed using a predefined fidelity coding index based on behavioural change technique taxonomy.
Ethics and dissemination: The study complies with the guidelines of the Declaration of Helsinki. Ethics approval for the study and process evaluation was granted by the University of Leeds (qualitative components), University of York (trial data and fidelity assessment), Bangladesh Medical Research Council and Bangladesh Drug Administration (trial data and qualitative components) and Pakistan Medical Research Council (trial data and qualitative components). Results of this research will be disseminated through reports to stakeholders and peer-reviewed publications and conference presentations.
Trial registration number: ISRCTN43811467; Pre-results.
Keywords: clinical trials; epidemiology; organisation of health services; public health; qualitative research; tuberculosis.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: EK, KZ and AP received payment for clinical studies and educational activities from Pfizer. They received no funding from a cytisine producing pharmaceutical company. KS received a research grant from Pfizer (2015–2017) to study the effect of varenicline (a smoking cessation medicine) on waterpipe smoking cessation.
Figures
Similar articles
- Interventions to reduce harm from continued tobacco use.Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T.Lindson-Hawley N, et al.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.Cochrane Database Syst Rev. 2016.PMID:27734465Free PMC article.Review.
- mHealth intervention (mTB-Tobacco) for smoking cessation in people with drug-sensitive pulmonary tuberculosis in Bangladesh and Pakistan: protocol for an adaptive design, cluster randomised controlled trial (Quit4TB).Zahid M, Rahman F, Chowdhury A, Rana SH, Ansaari S, Lim AK, Danaee M, Boeckmann M, Parrott S, Norrie J, Khan A, Huque R, Siddiqi K; RESPIRE Group.Zahid M, et al.BMJ Open. 2025 Feb 25;15(2):e089007. doi: 10.1136/bmjopen-2024-089007.BMJ Open. 2025.PMID:40000077
- A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.Coulton S, Nizalova O, Pellatt-Higgins T, Stevens A, Hendrie N, Marchand C, Vass R, Deluca P, Drummond C, Ferguson J, Waller G, Newbury-Birch D.Coulton S, et al.Public Health Res (Southampt). 2023 Mar;11(3):1-77. doi: 10.3310/FKPY6814.Public Health Res (Southampt). 2023.PMID:37254608
- Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF.Elwenspoek MM, et al.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371.Health Technol Assess. 2022.PMID:36321689Free PMC article.
- Strategies to improve smoking cessation rates in primary care.Lindson N, Pritchard G, Hong B, Fanshawe TR, Pipe A, Papadakis S.Lindson N, et al.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.Cochrane Database Syst Rev. 2021.PMID:34693994Free PMC article.Review.
Cited by
- Nicotine receptor partial agonists for smoking cessation.Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N.Livingstone-Banks J, et al.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.Cochrane Database Syst Rev. 2023.PMID:37142273Free PMC article.Review.
- Health worker and patient views on implementation of smoking cessation in routine tuberculosis care.Boeckmann M, Warsi S, Noor M, Dogar O, Mustagfira EH, Firoze F, Zahid R, Readshaw A, Siddiqi K, Kotz D; TB & Tobacco Consortium.Boeckmann M, et al.NPJ Prim Care Respir Med. 2019 Sep 3;29(1):34. doi: 10.1038/s41533-019-0146-6.NPJ Prim Care Respir Med. 2019.PMID:31481678Free PMC article.
- #LetsUnlitterUK: A demonstration and evaluation of the Behavior Change Wheel methodology.Kolodko J, Schmidtke KA, Read D, Vlaev I.Kolodko J, et al.PLoS One. 2021 Nov 16;16(11):e0259747. doi: 10.1371/journal.pone.0259747. eCollection 2021.PLoS One. 2021.PMID:34784385Free PMC article.
- IMPACT smoking cessation support for people with severe mental illness in South Asia (IMPACT 4S): A protocol for a randomised controlled feasibility trial of a combined behavioural and pharmacological support intervention.Mazumdar P, Zavala G, Aslam F, Muliyala KP, Chaturvedi SK, Kandasamy A, Nizami A, Ul Haq B, Kellar I, Jackson C, Thomson H, McDaid D, Siddiqi K, Hewitt C, Siddiqi N, Gilbody S, Murthy P, Dadirai Mdege N.Mazumdar P, et al.PLoS One. 2023 Jun 14;18(6):e0287185. doi: 10.1371/journal.pone.0287185. eCollection 2023.PLoS One. 2023.PMID:37315070Free PMC article.
- Process evaluation of a complex intervention to promote advance care planning in community-dwelling older persons (the STADPLAN study)-study protocol.Silies K, Schnakenberg R, Berg A, Kirchner Ä, Langner H, Köberlein-Neu J, Meyer G, Hoffmann F, Köpke S.Silies K, et al.Trials. 2020 Jul 16;21(1):653. doi: 10.1186/s13063-020-04529-2.Trials. 2020.PMID:32678005Free PMC article.
References
- World Health Organization. Global Tuberculosis Report 2017: Leave no one behind - Unite to end TB. Geneva: World Health Organization, 2017.
- World Health Organization. Tuberculosis & Tobacco: a strong association. TB Tob. Factsheet. 2009.http://www.who.int/tobacco/resources/publications/factsheet_tb_tobacco_s... (accessed 30 May 2017).
Publication types
MeSH terms
Associated data
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases